3455 Healthcare & Medical Investment Corporation - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3455

TSE REIT

Healthcare & Medical Investment Corporation

115,800

JPY

-500

(-0.43%)

Dec 5, 2:22 pm JST

748.01

USD

Dec 5, 12:22 am EST

Result

ー

PTS

outside of trading hours

115,800

Dec 5, 2:22 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2024	2,438	1,254	1,050	1,049	2,919.0	3,235	Mar 19, 2024	J-GAAP
Jul, 2024	2,514	1,298	1,055	1,054	2,934.0	3,261	Sep 13, 2024	J-GAAP
Jan, 2025	2,522	1,273	1,025	1,024	2,850.0	3,183	Mar 18, 2025	J-GAAP
Jul, 2025	2,547	1,286	1,017	1,017	2,829.0	3,164	Sep 12, 2025	J-GAAP
Jan, 2026 Guidance	2,635	1,341	1,046	1,045	2,906.8	3,250	Sep 12, 2025	J-GAAP
YoY	+3.5%	+4.3%	+2.9%	+2.8%	+2.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jan, 2023	Sep 14, 2022	2,419	1,241	1,065	1,064	3275	J-GAAP
	Sep 21, 2022	2,621	1,429	1,253	1,252	3484	J-GAAP
Results	Mar 17, 2023	2,632	1,453	1,279	1,278	3557	J-GAAP
Jul, 2023	Mar 17, 2023	2,438	1,264	1,063	1,062	3265	J-GAAP
Results	Sep 15, 2023	2,438	1,268	1,068	1,068	3282	J-GAAP
Jan, 2024	Sep 15, 2023	Available in future release
Results	Mar 19, 2024
Jul, 2024	Mar 19, 2024
Results	Sep 13, 2024
Jan, 2025	Sep 13, 2024
Results	Mar 18, 2025
Jul, 2025	Mar 18, 2025
Results	Sep 12, 2025
Jan, 2026	Sep 12, 2025	2,635	1,341	1,046	1,045	3250	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jul, 2015	546	－	Available in future release
Jan, 2016	745	－
Jul, 2016	771	+41.2
Jan, 2017	784	+5.2
Jul, 2017	1,162	+50.7
Jan, 2018	1,219	+55.5
Jul, 2018	1,267	+9.0
Jan, 2019	1,301	+6.7
Jul, 2019	2,008	+58.5
Jan, 2020	2,013	+54.7
Jul, 2020	2,023	+0.7
Jan, 2021	2,058	+2.2
Jul, 2021	2,073	+2.5
Jan, 2022	2,080	+1.1
Jul, 2022	2,371	+14.4
Jan, 2023	2,632	+26.5
Jul, 2023	2,438	+2.8
Jan, 2024	2,438	-7.4
Jul, 2024	2,514	+3.1
Jan, 2025	2,522	+3.4
Jul, 2025	2,547	+1.3
Jan, 2026 Guidance	2,635	+4.5	1,341	+5.3	1,046	+2.0	2,906.8	+2.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jan, 2025	2,522	1,273	50.5	ー	ー	ー	2,850.0
Jul, 2025	2,547	1,286	50.5	ー	ー	ー	2,829.0
Jan, 2026 Guidance	2,635	1,341	50.9	ー	ー	ー	2,906.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	2,632	1,453	1,279	1,278	3,555.0
Fiscal Year	Jan, 2023	Jan, 2023	Jan, 2023	Jan, 2023	Jan, 2023

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jul, 2024	1,298	-1,076	1,704	-2,780	1,236	2,135	2.56	J-GAAP
Jan, 2025	1,273	180	1,682	-1,502	-91	2,223	2.63	J-GAAP
Jul, 2025	1,286	1,337	1,616	-279	-1,146	2,413	2.86	J-GAAP

Actual Performance and Financial Trends

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	－	－	－	－	－
Fiscal Year	－	－	－	－	－

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jul, 2024	107,510.00	46.3	83,456	38,649	1,056	1.03	Sep 13, 2024	J-GAAP
Jan, 2025	107,378.00	45.6	84,606	38,602	1,024	1.06	Mar 18, 2025	J-GAAP
Jul, 2025	107,150.00	45.6	84,495	38,520	1,017	1.06	Sep 12, 2025	J-GAAP

Healthcare & Medical Investment Corporation(3455) Financial Results